4.86 USD
▲+0.08+5.42%
盘后 4.54 -1.46%
2026-08-03
市值
$285.35M
市盈率
—
EPS
-1.17
股息率
—
52 周区间
3.27 – 6.95
成交量
160.82K
Beta
2.86
目标价
11.44
52W 低 3.2752W 高 6.95
价格走势
公司简介
Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of medicines targeting genetically determined dependencies within the chromatin regulatory system in the United States. The company uses its proprietary Gene Traffic Control platform to identify, validate, and potentially drug targets within the system. It is developing therapies for mutant; non-small cell lung; endometrial, cervical, ovarian, and bladder cancer; and diffuse large B-cell lymphoma, as well as various acute myeloid leuk...